Table 2.
Comparison of the NerveCheck Results of Controls, Subjects with Diabetes With and Without Numbness and With and Without Neuropathic Pain Defined by the McGill Pain Questionnaire
| Deficits | Controls | No numbness | Numbness | No pain | Pain |
|---|---|---|---|---|---|
| n | 69 | 28 | 45 | 56 | 18 |
| Signs/Total No. of subjects (%) | 4/69 (6) | 12/28 (43) | 30/45 (67) | 28/56 (50) | 14/18 (78) |
| NerveCheck VPT | 8.98 ± 0.37***, *** | 5.4 ± 1.02 | 3.75 ± 0.68*** | 5 ± 0.65*** | 2.67 ± 0.9* |
| NerveCheck CPT | 5.89 ± 0.07***, *** | 5.3 ± 0.28 | 4.11 ± 0.38*** | 4.78 ± 0.28*** | 3.61 ± 0.66 |
| NerveCheck WPT | 4.74 ± 0.25***, * | 5.15 ± 0.31** | 3.88 ± 0.4*** | 4.72 ± 0.29 | 3.17 ± 0.63* |
Data are mean ± standard error of the mean, P-values are derived by unpaired t-test: *P ≤ 0.05, **P ≤ 0.001, ***P ≤ 0.0001. The P-values for controls versus numbness and painful symptoms are in the control column, respectively, controls versus no symptoms are in the no symptom columns, and present versus absent symptoms are in the symptom columns.